July 21, 2019
  • 2:34 pm Committee Leadership Comes into Focus for 116th Congress
  • 2:22 pm Interstate System Report Calls for More Funding, Tolling, VMT Fees, and Cybersecurity
  • 2:15 pm In Memoriam: President George H. W. Bush, ISTEA, and Transportation
  • 1:56 pm Growth Projected for Transportation Projects, but Costs a Challenge
  • 1:35 pm FAA Reshuffles Executives, Plans Drone Identification Rulemaking in Spring 2019
  • 1:28 pm Predictive Technology Helps Reduce Crashes on I-15 Corridor in Las Vegas
  • 1:14 pm Video Report: MoDOT Produces Multi-Lingual Safety Message
  • 1:11 pm PennDOT Nears Completion of Rapid Bridge Replacement Project
  • 1:08 pm Infrastructure Grants Awarded to “Smaller” South Dakota Communities
  • 12:28 pm Contentious House Hearing Examines FTA’s CIG Program, HTF Impact
  • 12:20 pm FHWA’s Hendrickson to Become AASHTO’s Deputy Director
  • 12:16 pm GAO Report Finds INFRA Grant Program Lacks Consistency, Transparency
  • 12:11 pm FHWA’s Nason Highlights Need to Reserve 5.9 GHz Spectrum for Transportation
  • 12:07 pm USDOT, FMCSA Step-Up Efforts to Deter Human Trafficking

A final rule issued by the Federal Motor Carrier Safety Administration on Sept. 19 will allow diabetic individuals with a “stable insulin regimen” and properly controlled “insulin-treated diabetes mellitus” or ITDM to be qualified to operate commercial motor vehicles or CMVs in interstate commerce.

Previously, individuals with ITDM were prohibited from driving CMVs in interstate commerce unless they obtained specific written exemption from the FMCSA, the agency said.

Oklahoma DOT

The new rule enables a certified medical examiner or ME to grant an individual with ITDM a Medical Examiner’s Certificate, MCSA-5876, for up to 12 months, with the ME subsequently responsible for determining if the individual meets FMCSA’s physical qualification standards and can operate CMVs in interstate commerce.

It also eliminates the exemption program that currently requires some 5,000 individuals with ITDM to incur more than $5 million in costs as a group on a yearly basis to renew and maintain their exemptions. The agency itself expects to save more than $1 million per year over the next three years in costs associated with administering its diabetes exemption program.

editor@aashto.org

RELATED ARTICLES
%d bloggers like this: